The Xa factor: not looking so promising for Pfizer and Bristol - Bristol-Myers Squibb and Pfizer's apixaban blood clot preventer raised rates of bleeding in a 6-month study but showed some encouraging …
Pharma News 10_19
The Good Stuff: BMS gets approval for new oncology drug (for breast cancer) Ixempra. Merck gets new HIV drug (Isentress) approved in the U.S. And, their Januvia diabetes drug gets new uses …